Two Prodrugs of Potent and Selective GluR5 Kainate Receptor Antagonists Actives in Three Animal Models of Pain
2005; American Chemical Society; Volume: 48; Issue: 13 Linguagem: Inglês
10.1021/jm0491952
ISSN1520-4804
AutoresEsteban Domı́nguez, Smriti Iyengar, Harlan E. Shannon, David Bleakman, Andrew Alt, Brian M. Arnold, Michael G. Bell, Thomas J. Bleisch, Jennifer L. Buckmaster, Ana M. Castaño‐León, Miriam Del Prado, Ana Escribano, Sandra Filla, Ken H. Ho, Kevin J. Hudziak, Carrie K. Jones, José Antonio Martínez-Pérez, Ana Mateo, Brian M. Mathes, Edward L. Mattiuz, Ann Marie L. Ogden, Rosa Maria A. Simmons, Douglas R. Stack, Robert E. Stratford, Mark A. Winter, Zhipei Wu, Paul L. Ornstein,
Tópico(s)Bioactive Compounds and Antitumor Agents
ResumoAmino acids 5 and 7, two potent and selective competitive GluR5 KA receptor antagonists, exhibited high GluR5 receptor affinity over other glutamate receptors. Their ester prodrugs 6 and 8 were orally active in three models of pain: reversal of formalin-induced paw licking, carrageenan-induced thermal hyperalgesia, and capsaicin-induced mechanical hyperalgesia.
Referência(s)